North America

After an era of exuberance, expansion and ‘rockstar’ roles, sustainability in private markets is being more closely tethered to value creation.

TMT-focused vehicles are getting bigger and more often closing on target, despite the wider fundraising malaise.

Regulatory stability, an abundance of dry powder and a strong pipeline of assets make medtech a compelling place to put capital to work, says DC Advisory’s Manish Gupta.

The IPO market is now open for quality tech stocks, and increased M&A activity will likely soon follow, say Adams Street Partners’ Brijesh Jeevarathnam and Robin Murray.

Large take-privates and carve-outs are on the menu as PE firms seek opportunities to unlock and drive value, says Baker McKenzie’s Eric Schwartzman.

Tech companies are well placed to answer PE sponsors’ growing questions about AI readiness, helping to buoy appetite for the sector, say KPMG’s Anuj Bahal, Patrick Carpenter and Greg Sward.

Private equity sponsors continue to target tech companies developing mission-critical technology for the lucrative and rapidly evolving wealth management industry.